Document is current
Any future updates will be listed below
-
Authors
Mahamad Maifiah, Mohd Hafidz
Zhu, Yan
Tsuji, Brian T.
Creek, Darren J.
Velkov, Tony
Li, Jian
-
Funding
Funding for this research was provided by:
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01 AI132681, AI132154)
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 21 October 2022
First Online: 30 October 2022
Declarations
:
: Not applicable.
: Not applicable.
: JL and TV licensed their new-generation polymyxin molecules to Qpex Biopharma. JL received grant support, seminar honorarium and consultation fees from Northern Antibiotics, Qpex Biopharma, Avexa, Genentech, Healcare, CTTQ, Aosaikang, Jiayou Medicine, MedCom, DanDi BioScience, and Xellia ApS. The other authors declare that they have no competing interests.
